Barbara Klencke - 06 Apr 2023 Form 3 Insider Report for TScan Therapeutics, Inc. (TCRX)

Role: Director
Signature: /s/ Barbara Klencke
Issuer symbol: TCRX
Transactions as of: 06 Apr 2023
Net transactions value: $0
Form type: 3
Filing time: 10 Apr 2023, 10:35:53 UTC
Previous filing: 24 Jan 2023
Next filing: 15 Jun 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	TCRX	Voting Common Stock						25,000	06 Apr 2023	Direct
holding	TCRX	Voting Common Stock						25,000	06 Apr 2023	By Trust	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Shares held by the Klencke Huestis Trust, for which the Reporting Person serves as co-trustee along with her spouse. The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

Content

Shares held by the Klencke Huestis Trust, for which the Reporting Person serves as co-trustee along with her spouse. The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.